Pages that link to "Q39999306"

The following pages link to Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors (Q39999306):

Displaying 19 items.

• Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways (Q30458494) (← links)
• Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma (Q34271064) (← links)
• The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer (Q34649075) (← links)
• Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models (Q35590793) (← links)
• Perifosine enhances mTORC1-targeted cancer therapy by activation of GSK3β in NSCLC cells (Q36289873) (← links)
• Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells (Q36560547) (← links)
• Targeting prostate cancer based on signal transduction and cell cycle pathways. (Q36995054) (← links)
• Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy (Q37227994) (← links)
• Perifosine: update on a novel Akt inhibitor. (Q37393008) (← links)
• Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine (Q38474631) (← links)
• Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models. (Q38848501) (← links)
• Combination treatment with perifosine and MEK-162 demonstrates synergism against lung cancer cells in vitro and in vivo (Q38907955) (← links)
• Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models (Q39006052) (← links)
• Investigational serine/threonine kinase inhibitors against prostate cancer metastases (Q39021945) (← links)
• AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers (Q39115952) (← links)
• Mature breast adipocytes promote breast cancer cell motility (Q39374509) (← links)
• Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells (Q39625216) (← links)
• Prostate cancer health disparities: An immuno-biological perspective (Q46537204) (← links)
• Deciphering the scalene association among type-2 diabetes mellitus, prostate cancer, and chronic myeloid leukemia via enrichment analysis of disease-gene network. (Q64914303) (← links)